Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromuscular blockers.

J M Gracies1, D Simpson

  • 1Department of Neurology, Mount Sinai Medical Center, New York, New York, USA. jean-michel.gracies@smtplink.mssm.edu

Physical Medicine and Rehabilitation Clinics of North America
|June 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caring for yourself while you care for someone else: a qualitative study exploring the mental and cardiovascular health behaviours of female carers of stroke survivors.

Disability and rehabilitation·2024
Same author

Fibrinogen-Related Protein, Fgl2, of Hamster Cauda Epididymal Fluid: Enzymatic Characterization, and Identification of Fgl2-Binding Proteins and Ligand of Defective Hamster Sperm Organelles.

International journal of biochemistry & physiology·2024
Same author

Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial.

Stem cell research & therapy·2022
Same author

Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism.

Acta endocrinologica (Bucharest, Romania : 2005)·2022
Same author

An unusual presentation of dysarthria in a young patient, a stroke mimic.

Acute medicine·2021
Same author

Mapping the contact area of the patellofemoral joint: the relationship between stability and joint congruence.

The bone & joint journal·2019
Same journal

Preface.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Unbound: A Comprehensive Review.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Dual Frontiers Cancer and Palliative Care.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Management Across Special Populations: Pediatrics, Geriatrics, and Pregnancy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Healing from Within: Regenerative Medicine in Pain Therapy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

The Brain in Pain: Exploring Central Pain Disorders.

Physical medicine and rehabilitation clinics of North America·2026
See all related articles

Injectable treatments like botulinum toxin (BTX) offer localized solutions for muscle overactivity. This review covers BTX, anesthetics, alcohol, and phenol for managing these conditions.

Area of Science:

  • Neurology
  • Pharmacology
  • Physical Medicine

Background:

  • Historically, corrosive injectable neuromuscular blockers were used for muscle overactivity.
  • Botulinum toxin (BTX) has renewed interest in localized treatment approaches.

Purpose of the Study:

  • To review the applications of various injectable agents for localized muscular overactivity syndromes.
  • To compare the efficacy and use of different treatment options.

Main Methods:

  • Literature review of studies on local anesthetics, alcohol, phenol, and botulinum toxin.
  • Analysis of treatment outcomes for localized muscular overactivity.

Main Results:

  • Botulinum toxin (BTX) is a significant advancement in localized muscle overactivity treatment.

Related Experiment Videos

  • Local anesthetics, alcohol, and phenol are also discussed as therapeutic options.

    • Conclusions:

    • Botulinum toxin (BTX) offers a refined approach to managing localized muscular overactivity.
    • A range of injectable agents provide options for tailored patient treatment.